Description
How It Works
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH). It acts on the pituitary to stimulate natural pulsatile growth hormone release, which then supports downstream IGF-1 activity. This makes it relevant for protocols focused on visceral fat, metabolic support, body composition, and broader GH-axis support.
Tesamorelin is generally chosen where the goal is stronger endogenous growth hormone signaling rather than direct hormone replacement. In practical use, it is often positioned as a more advanced option for abdominal-fat focused protocols, metabolic support, and recovery-aligned body composition planning.
Dosage Protocol
Growth hormone support: 1.00 – 2.00mg.
Advanced visceral fat / body composition support: 2.00mg.
Notes:
• Evening use on an empty stomach.
• Administer approximately 90 minutes after the last meal.
Cycle length: Use daily for up to 26 weeks, then reassess before continuing.
Each cartridge contains 3mL bacteriostatic water (300 units)
KEEP REFRIGERATED.
Expected Outcomes
Tesamorelin 20mg is typically used where the goal is stronger GH-axis support, improved IGF-1 signalling, and better support for visceral fat and body composition goals.
- Stronger endogenous growth hormone signalling
- Improved IGF-1 activity
- Support for reduction in abdominal visceral fat
- Improved metabolic support
- Better alignment with body-composition focused protocols
- Support for recovery-focused planning
Cautions and Warnings
Not suitable for people under the age of 18.
Not suitable during pregnancy.
Not suitable while breastfeeding.
Related Products
- Ipamorelin 5mg — GH secretagogue pairing
- CJC-1295 — complementary GH-pathway support
- Sermorelin — alternative GHRH analogue option
- BPC-157 & TB-500 — recovery and tissue-support pairing
- MOTS-c — metabolic support pairing